The Grand SANS FLUORO (SAy No Series to FLUOROsopy) Study: Examining Fluoroscopy Use in More than 1,000 Ablation Procedures
Journal of Innovations in Cardiac Rhythm Management · 01.09.2020 · 11 (9) · 4224-4232
DOI: 10.19102/icrm.2020.1100903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Innovations in Cardiac Rhythm Management, online erschienen am 20.09.2020. Verfasst von Robert L Percell und 14 weiteren Autor:innen. Beteiligte Einrichtung: SANS FLUORO Institute, Electrophysiology Department, Bryan Heart Institute, Lincoln, NE, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The majority of electrophysiologists routinely use fluoroscopy (FLUORO) during ablation procedures for common arrhythmias despite the known complications of radiation exposure and protective lead use. This study assessed the safety of catheter ablation (CA) with FLUORO versus without FLUORO (SANS FLUORO) in patients with the following common arrhythmias: atrial fibrillation (AF), atrial flutter, supraventricular tachycardia, and ventricular tachycardia. A total of 1,258 CA procedures were performed in 816 consecutive patients over a 53-month period (SANS FLUORO CA: 609 patients; FLUORO CA: 209 patients). The secondary outcome was the efficacy of AF ablation in FLUORO versus SANS FLUORO patients. Ultimately, there was no statistically significant difference found concerning the safety of CA in the SANS FLUORO and FLUORO groups in terms of procedure time, vascular complications, tamponade, stroke, or death. FLUORO patients had markedly increased FLUORO time, increased radiation exposure, and increased dose-area product (all p < 0.0001). AF development after SANS FLUORO CA of AF was not different from that after FLUORO CA regardless of the pulmonary vein isolation (PVI) modality used (cryoablation versus radiofrequency) at 24 months (p = 0.21). Additionally, women fared just as well as men after CA ablation for AF. At 36 months, 58% of SANS FLUORO AF device patients were free from AF. As such, SANS FLUORO CA of common arrhythmias appears to be as safe as FLUORO CA but with a markedly reduced level of radiation exposure. Also, SANS FLUORO CA remains as effective as FLUORO CA in the prevention of AF for up to 24 months.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SANS FLUORO Institute, Electrophysiology Department, Bryan Heart Institute, Lincoln, NE, USA.
- Bryan Heart Institute, Lincoln, NE, USA.
- Abbott Medical, Abbott Laboratories, Abbott Park, IL, USA.
- Lake Region Healthcare, Morris, MN, USA.
Zitieren
APA
Percell, R. L., Pike, J. L., Olmsted, R. K., Beideck, J. E., Nunes, H. L., Johnson, K. N., Schaffer, M., Vachok, L. B., Sveen, S. M., Keim, E. J., Mohr-Burt, S. O., Saalfeld, R. M., Beran, C. A., Allison, T. W., & Stock, J. F. (2020). The Grand SANS FLUORO (SAy No Series to FLUOROsopy) Study: Examining Fluoroscopy Use in More than 1,000 Ablation Procedures. Journal of Innovations in Cardiac Rhythm Management, 11(9), 4224-4232. https://doi.org/10.19102/icrm.2020.1100903
Vancouver
Percell RL, Pike JL, Olmsted RK, Beideck JE, Nunes HL, Johnson KN, et al. The Grand SANS FLUORO (SAy No Series to FLUOROsopy) Study: Examining Fluoroscopy Use in More than 1,000 Ablation Procedures. Journal of Innovations in Cardiac Rhythm Management. 2020;11(9):4224-4232. doi:10.19102/icrm.2020.1100903
BibTeX
@article{Percell2020,
author = {Percell, Robert L and Pike, Jonathan L and Olmsted, Rhonda K and Beideck, Jenna E and Nunes, Haley L and Johnson, Kellie N and Schaffer, Matthew and Vachok, Lindy B and Sveen, Stacy M and Keim, Emily J and Mohr-Burt, Shirley O and Saalfeld, Rose M and Beran, Casey A and Allison, Timothy W and Stock, John F},
title = {The Grand SANS FLUORO (SAy No Series to FLUOROsopy) Study: Examining Fluoroscopy Use in More than 1,000 Ablation Procedures},
journal = {Journal of Innovations in Cardiac Rhythm Management},
year = {2020},
volume = {11},
number = {9},
pages = {4224--4232},
doi = {10.19102/icrm.2020.1100903}
}
EUVIMED